Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- An oral antiviral drug to stop the virus that causes COVID-19 from replicating could be ready next year “if all goes right,” Pfizer Inc (NYSE: PFE) CEO Albert Bourla told CNBC.
- He also added that the drug should work against all variants of the virus.
- Pfizer is conducting the stage one clinical trial on an oral antiviral therapy that a patient could take when developing symptoms.
- Early-stage U.S. trial of an oral COVID-19 antiviral therapy, dubbed PF-07321332, was started in March this year.
- Up to 60 healthy volunteers aged between 18 and 60 will be included in the trial. The study will run for 145 days, with another 28 days added for “screening and dosing.”
- Pfizer is also working on an intravenously administered protease inhibitor, known as PF-07304814. That drug is currently in a Phase 1b clinical trial in patients hospitalized with COVID-19.
- The drug is based on “protease inhibiting” technology and works by inhibiting an enzyme that the virus needs to replicate in human cells.
- Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.
- In addition to the drug, Pfizer is still testing its vaccine in 6-month to 11-year-old children.
- Earlier this month, the company asked the FDA to expand its vaccine authorization to adolescents ages 12 to 15 after the shot was 100% effective in a study.
- Price Action: PFE shares are down 0.63% at $38.44 in market trading hours on the last check Tuesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!